Ahmed, R.M. et al. (2016) ‘Neuronal network disintegration: common pathways linking neurodegenerative diseases’, Journal of Neurology, Neurosurgery & Psychiatry, 87(11), pp. 1234–1241. Available at: https://doi.org/10.1136/jnnp-2014-308350.
Alzheimer’s Facts and Figures Report | Alzheimer’s Association (no date). Available at: https://www.alz.org/alzheimers-dementia/facts-figures.
Arash Asher (no date) ‘The effect of cancer treatment on cognitive function.’, undefined [Preprint]. Available at: https://www.semanticscholar.org/paper/The-effect-of-cancer-treatment-on-cognitive-Asher-Myers/6bdd550dab6cfad0714aa76dd2ee439ad983e4be.
Barker, R.A. and Williams-Gray, C.H. (2016) ‘Review: The spectrum of clinical features seen with alpha synuclein pathology’, Neuropathology and Applied Neurobiology, 42(1), pp. 6–19. Available at: https://doi.org/10.1111/nan.12303.
Bates, G.P. et al. (2015) ‘Huntington disease’, Nature Reviews Disease Primers [Preprint]. Available at: https://doi.org/10.1038/nrdp.2015.5.
Blennow, K., Hardy, J. and Zetterberg, H. (2012) ‘The Neuropathology and Neurobiology of Traumatic Brain Injury’, Neuron, 76(5), pp. 886–899. Available at: https://doi.org/10.1016/j.neuron.2012.11.021.
Braak, H. and Braak, E. (1995) ‘Staging of alzheimer’s disease-related neurofibrillary changes’, Neurobiology of Aging, 16(3), pp. 271–278. Available at: https://doi.org/10.1016/0197-4580(95)00021-6.
Bras, J. et al. (2014) ‘Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies’, Human Molecular Genetics, 23(23), pp. 6139–6146. Available at: https://doi.org/10.1093/hmg/ddu334.
Carroll, J.B. et al. (2015) ‘Treating the whole body in Huntington’s disease’, The Lancet Neurology, 14(11), pp. 1135–1142. Available at: https://doi.org/10.1016/S1474-4422(15)00177-5.
Clarke, C. et al. (eds) (2016) Neurology: a Queen Square textbook. Second edition. Chichester, West Sussex, UK: Wiley Blackwell. Available at: https://onlinelibrary.wiley.com/doi/book/10.1002/9781118486160.
‘Cognitive Impairment Associated with Cancer: A Brief Review’ (2018) Innovations in Clinical Neuroscience, 15(1–2). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819720/.
Collinge, J. (2016) ‘Mammalian prions and their wider relevance in neurodegenerative diseases’, Nature, 539(7628), pp. 217–226. Available at: https://doi.org/10.1038/nature20415.
De Chiara, G. et al. (2012) ‘Infectious Agents and Neurodegeneration’, Molecular Neurobiology, 46(3), pp. 614–638. Available at: https://doi.org/10.1007/s12035-012-8320-7.
Devenney, E. et al. (2015) ‘Motor neuron disease-frontotemporal dementia: a clinical continuum’, Expert Review of Neurotherapeutics, 15(5), pp. 509–522. Available at: https://doi.org/10.1586/14737175.2015.1034108.
Dobson, R. and Alvares, D. (2016) ‘The difficulties with vitamin B’, Practical Neurology, 16(4), pp. 308–311. Available at: https://doi.org/10.1136/practneurol-2015-001344.
Dubois, B. et al. (2014) ‘Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria’, The Lancet Neurology, 13(6), pp. 614–629. Available at: https://doi.org/10.1016/S1474-4422(14)70090-0.
Fleminger, S. (2003) ‘Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication’, Journal of Neurology, Neurosurgery & Psychiatry, 74(7), pp. 857–862. Available at: https://doi.org/10.1136/jnnp.74.7.857.
Fletcher, P.D. and Warren, J.D. (2011) ‘Semantic Dementia: a specific network-opathy’, Journal of Molecular Neuroscience, 45(3), pp. 629–636. Available at: https://doi.org/10.1007/s12031-011-9586-3.
Ghanem, K.G. (2010) ‘REVIEW: Neurosyphilis: A Historical Perspective and Review’, CNS Neuroscience & Therapeutics, 16(5), pp. e157–e168. Available at: https://doi.org/10.1111/j.1755-5949.2010.00183.x.
Goll, J.C. et al. (2010) ‘Non-verbal sound processing in the primary progressive aphasias’, Brain, 133(1), pp. 272–285. Available at: https://doi.org/10.1093/brain/awp235.
Goll, J.C. et al. (2012) ‘Nonverbal sound processing in semantic dementia: A functional MRI study’, NeuroImage, 61(1), pp. 170–180. Available at: https://doi.org/10.1016/j.neuroimage.2012.02.045.
Goll, J.C., Crutch, S.J. and Warren, J.D. (2010) ‘Central auditory disorders: toward a neuropsychology of auditory objects’, Current Opinion in Neurology, 23(6), pp. 617–627. Available at: https://doi.org/10.1097/WCO.0b013e32834027f6.
Gordon, E., Rohrer, J.D. and Fox, N.C. (2016) ‘Advances in neuroimaging in frontotemporal dementia’, Journal of Neurochemistry, 138, pp. 193–210. Available at: https://doi.org/10.1111/jnc.13656.
Gorelick, P.B. et al. (2011) ‘Vascular Contributions to Cognitive Impairment and Dementia’, Stroke, 42(9), pp. 2672–2713. Available at: https://doi.org/10.1161/STR.0b013e3182299496.
Gorno-Tempini, M.L. et al. (2011) ‘Classification of primary progressive aphasia and its variants’, Neurology, 76(11), pp. 1006–1014. Available at: https://doi.org/10.1212/WNL.0b013e31821103e6.
Graus, F. et al. (2016a) ‘A clinical approach to diagnosis of autoimmune encephalitis’, The Lancet Neurology, 15(4), pp. 391–404. Available at: https://doi.org/10.1016/S1474-4422(15)00401-9.
Graus, F. et al. (2016b) ‘A clinical approach to diagnosis of autoimmune encephalitis’, The Lancet Neurology, 15(4), pp. 391–404. Available at: https://doi.org/10.1016/S1474-4422(15)00401-9.
Green, A.J.E. (2018) ‘RT-QuIC: a new test for sporadic CJD’, Practical Neurology [Preprint]. Available at: https://doi.org/10.1136/practneurol-2018-001935.
Grossman, M. (2012) ‘The non-fluent/agrammatic variant of primary progressive aphasia’, The Lancet Neurology, 11(6), pp. 545–555. Available at: https://doi.org/10.1016/S1474-4422(12)70099-6.
Hachinski, V. et al. (2006) ‘National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards’, Stroke, 37(9), pp. 2220–2241. Available at: https://doi.org/10.1161/01.STR.0000237236.88823.47.
Haddow, L.J., Cartledge, J.D. and Manji, H. (2013) ‘HIV and the brain: from AIDS to old age’, Clinical Medicine, 13(Suppl_6), pp. s24–s28. Available at: https://doi.org/10.7861/clinmedicine.13-6-s24.
Halliday, G.M. et al. (2011) ‘Neuropathology underlying clinical variability in patients with synucleinopathies’, Acta Neuropathologica, 122(2), pp. 187–204. Available at: https://doi.org/10.1007/s00401-011-0852-9.
Halperin, J.J. et al. (2015) ‘Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response’, Neurology, 85(23), pp. 2063–2071. Available at: https://doi.org/10.1212/WNL.0000000000002193.
Hardy, C.J.D. et al. (2016) ‘Hearing and dementia’, Journal of Neurology, 263(11), pp. 2339–2354. Available at: https://doi.org/10.1007/s00415-016-8208-y.
Hereditary and sporadic beta-amyloidoses (no date). Available at: https://www.bioscience.org/2013/v18/af/4173/fulltext.htm.
HIV in the United Kingdom 2016 infographic (no date). Available at: https://www.gov.uk/government/publications/hiv-in-the-united-kingdom.
Hodges, J.R. (2017) Cognitive assessment for clinicians. 3 ed. [Oxford]: Oxford University Press. Available at: http://dx.doi.org/10.1093/med/9780198749189.001.0001.
Hollak, C.E.M. and Lachmann, R. (eds) (2016) Inherited metabolic disease in adults: a clinical guide [electronic resource]. [New York]: Oxford University Press. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3043210560004761&institutionId=4761&customerId=4760.
Husain, M. (2016a) Oxford textbook of cognitive neurology and dementia. Edited by M. Husain, J.M. Schott, and C. Kennard. [Oxford]: Oxford University Press. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909605720004761&institutionId=4761&customerId=4760.
Husain, M. (2016b) Oxford textbook of cognitive neurology and dementia. Edited by M. Husain, J.M. Schott, and C. Kennard. [Oxford]: Oxford University Press. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3119511110004761&institutionId=4761&customerId=4760.
Iranzo, A. et al. (2014) ‘Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients’, PLoS ONE, 9(2). Available at: https://doi.org/10.1371/journal.pone.0089741.
Itzhaki, R.F. et al. (2016) ‘Microbes and Alzheimer’s Disease’, Journal of Alzheimer’s Disease, 51(4), pp. 979–984. Available at: https://doi.org/10.3233/JAD-160152.
Johnson, G.V.W. (2004) ‘Tau phosphorylation in neuronal cell function and dysfunction’, Journal of Cell Science, 117(24), pp. 5721–5729. Available at: https://doi.org/10.1242/jcs.01558.
Johnson, K.A. et al. (2012) ‘Brain Imaging in Alzheimer Disease’, Cold Spring Harbor Perspectives in Medicine, 2(4), pp. a006213–a006213. Available at: https://doi.org/10.1101/cshperspect.a006213.
Jonathan Carr (2003) ‘Neurosyphilis’, Practical Neurology, 3, pp. 328–341. Available at: https://pn.bmj.com/content/3/6/328.
Jones, L., Houlden, H. and Tabrizi, S.J. (2017) ‘DNA repair in the trinucleotide repeat disorders’, The Lancet Neurology, 16(1), pp. 88–96. Available at: https://doi.org/10.1016/S1474-4422(16)30350-7.
Kandel, E.R. et al. (eds) (2013) Principles of neural science. Fifth edition. New York: McGraw Hill Medical. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909605810004761&institutionId=4761&customerId=4760.
Karran, E. and Hardy, J. (2014) ‘Antiamyloid Therapy for Alzheimer’s Disease — Are We on the Right Road?’, New England Journal of Medicine, 370(4), pp. 377–378. Available at: https://doi.org/10.1056/NEJMe1313943.
Kielb, S.A. et al. (2012) ‘Cognition in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAS): Current Clinical Knowledge and the Impact of Treatment’, NeuroMolecular Medicine, 14(3), pp. 180–193. Available at: https://doi.org/10.1007/s12017-012-8182-1.
Leys, D. et al. (2005) ‘Poststroke dementia’, The Lancet Neurology, 4(11), pp. 752–759. Available at: https://doi.org/10.1016/S1474-4422(05)70221-0.
Leyton, C.E. et al. (2015) ‘Is the logopenic-variant of primary progressive aphasia a unitary disorder?’, Cortex, 67, pp. 122–133. Available at: https://doi.org/10.1016/j.cortex.2015.03.011.
Livingston, G. et al. (2017) ‘Dementia prevention, intervention, and care’, The Lancet, 390(10113), pp. 2673–2734. Available at: https://doi.org/10.1016/S0140-6736(17)31363-6.
Loy, C.T. et al. (2014) ‘Genetics of dementia’, The Lancet, 383(9919), pp. 828–840. Available at: https://doi.org/10.1016/S0140-6736(13)60630-3.
Lynch, D.S. et al. (2017) ‘Clinical and genetic characterization of leukoencephalopathies in adults’, Brain, 140(5), pp. 1204–1211. Available at: https://doi.org/10.1093/brain/awx045.
Mander, B.A. et al. (2016) ‘Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer’s Disease?’, Trends in Neurosciences, 39(8), pp. 552–566. Available at: https://doi.org/10.1016/j.tins.2016.05.002.
Marshall, C.R. et al. (2018) ‘Primary progressive aphasia: a clinical approach’, Journal of Neurology, 265(6), pp. 1474–1490. Available at: https://doi.org/10.1007/s00415-018-8762-6.
McCarter, S.J., St. Louis, E.K. and Boeve, B.F. (2016) ‘Sleep Disturbances in Frontotemporal Dementia’, Current Neurology and Neuroscience Reports, 16(9). Available at: https://doi.org/10.1007/s11910-016-0680-3.
McCarthy, R.A. and Warrington, E.K. (1990) Cognitive neuropsychology: a clinical introduction. San Diego, California: Academic Press, Inc. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909618430004761&institutionId=4761&customerId=4760.
McKee, A.C. et al. (2013) ‘The spectrum of disease in chronic traumatic encephalopathy’, Brain, 136(1), pp. 43–64. Available at: https://doi.org/10.1093/brain/aws307.
McKeith, I.G. et al. (2017) ‘Diagnosis and management of dementia with Lewy bodies’, Neurology, 89(1), pp. 88–100. Available at: https://doi.org/10.1212/WNL.0000000000004058.
Mead, S. and Rudge, P. (2017) ‘CJD mimics and chameleons’, Practical Neurology, 17(2), pp. 113–121. Available at: https://doi.org/10.1136/practneurol-2016-001571.
Mirra, S.S. et al. (1991) ‘The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease’, Neurology, 41(4), pp. 479–479. Available at: https://doi.org/10.1212/WNL.41.4.479.
Montine, T.J. et al. (2012a) ‘National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach’, Acta Neuropathologica, 123(1), pp. 1–11. Available at: https://doi.org/10.1007/s00401-011-0910-3.
Montine, T.J. et al. (2012b) ‘National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach’, Acta Neuropathologica, 123(1), pp. 1–11. Available at: https://doi.org/10.1007/s00401-011-0910-3.
Nightingale, S. et al. (2013) ‘Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed’, Practical Neurology, 13(6), pp. 354–356. Available at: https://doi.org/10.1136/practneurol-2013-000689.
Nightingale, S. et al. (2014) ‘Controversies in HIV-associated neurocognitive disorders’, The Lancet Neurology, 13(11), pp. 1139–1151. Available at: https://doi.org/10.1016/S1474-4422(14)70137-1.
O’Brien, J.T. and Thomas, A. (2015) ‘Vascular dementia’, The Lancet, 386(10004), pp. 1698–1706. Available at: https://doi.org/10.1016/S0140-6736(15)00463-8.
Ooms, S. and Ju, Y.-E. (2016) ‘Treatment of Sleep Disorders in Dementia’, Current Treatment Options in Neurology, 18(9). Available at: https://doi.org/10.1007/s11940-016-0424-3.
‘Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales’ (2001) The Lancet, 357(9251), pp. 169–175. Available at: https://doi.org/10.1016/S0140-6736(00)03589-3.
Revesz, T. et al. (2009) ‘Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies’, Acta Neuropathologica, 118(1), pp. 115–130. Available at: https://doi.org/10.1007/s00401-009-0501-8.
Richard W. Price and Bruce J. Brew (1988) ‘The AIDS Dementia Complex’, The Journal of Infectious Diseases, 158(5). Available at: https://www.jstor.org/stable/30136610?seq=1#metadata_info_tab_contents.
Rohrer, J.D. et al. (2007) ‘Word-finding difficulty: a clinical analysis of the progressive aphasias’, Brain, 131(1), pp. 8–38. Available at: https://doi.org/10.1093/brain/awm251.
Rohrer, J.D. et al. (2010) ‘Progressive logopenic/phonological aphasia: Erosion of the language network’, NeuroImage, 49(1), pp. 984–993. Available at: https://doi.org/10.1016/j.neuroimage.2009.08.002.
Rohrer, J.D. et al. (2012) ‘Receptive prosody in nonfluent primary progressive aphasias’, Cortex, 48(3), pp. 308–316. Available at: https://doi.org/10.1016/j.cortex.2010.09.004.
Rohrer, J.D., Rossor, M.N. and Warren, J.D. (2010) ‘Syndromes of nonfluent primary progressive aphasia: A clinical and neurolinguistic analysis’, Neurology, 75(7), pp. 603–610. Available at: https://doi.org/10.1212/WNL.0b013e3181ed9c6b.
Ross, C.A. et al. (2014) ‘Huntington disease: natural history, biomarkers and prospects for therapeutics’, Nature Reviews Neurology, 10(4), pp. 204–216. Available at: https://doi.org/10.1038/nrneurol.2014.24.
Rossor, M. et al. (2016) ‘Dementia and Cognitive Impairment’, in C. Clarke et al. (eds) Neurology. Chichester, UK: John Wiley & Sons, Ltd, pp. 289–336. Available at: https://doi.org/10.1002/9781118486160.ch8.
Rossor, M. and Growdon, J.H. (2007) The dementias 2. [Place of publication not identified]: Butterworth Heinemann/Elsevier. Available at: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909618250004761&institutionId=4761&customerId=4760.
Rossor, M.N. et al. (2010) ‘The diagnosis of young-onset dementia’, The Lancet Neurology, 9(8), pp. 793–806. Available at: https://doi.org/10.1016/S1474-4422(10)70159-9.
Salvarani, C., Brown, R.D. and Hunder, G.G. (2012) ‘Adult primary central nervous system vasculitis’, The Lancet, 380(9843), pp. 767–777. Available at: https://doi.org/10.1016/S0140-6736(12)60069-5.
Schott, J.M., Fox, N.C. and Rossor, M.N. (2016) ‘Assessment and investigation of the cognitively impaired adult’, in M. Husain and J.M. Schott (eds) Oxford Textbook of Cognitive Neurology and Dementia. Oxford University Press, pp. 221–230. Available at: https://doi.org/10.1093/med/9780199655946.003.0021.
Scott, G. et al. (2016) ‘Amyloid pathology and axonal injury after brain trauma’, Neurology, 86(9), pp. 821–828. Available at: https://doi.org/10.1212/WNL.0000000000002413.
Selkoe, D.J. and Hardy, J. (2016) ‘The amyloid hypothesis of Alzheimer’s disease at 25 years’, EMBO Molecular Medicine, 8(6), pp. 595–608. Available at: https://doi.org/10.15252/emmm.201606210.
Smith, D.H., Johnson, V.E. and Stewart, W. (2013) ‘Chronic neuropathologies of single and repetitive TBI: substrates of dementia?’, Nature Reviews Neurology, 9(4), pp. 211–221. Available at: https://doi.org/10.1038/nrneurol.2013.29.
Somasundaram, O. (2009) ‘Neuro syphilis: Portrayals by Sir Arthur Conan Doyle’, Indian Journal of Psychiatry, 51(3). Available at: https://doi.org/10.4103/0019-5545.55103.
Strong, M.J. et al. (2017) ‘Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria’, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(3–4), pp. 153–174. Available at: https://doi.org/10.1080/21678421.2016.1267768.
Tabrizi, S.J. et al. (2011) ‘Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis’, The Lancet Neurology, 10(1), pp. 31–42. Available at: https://doi.org/10.1016/S1474-4422(10)70276-3.
Tabrizi, S.J. et al. (2012) ‘Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data’, The Lancet Neurology, 11(1), pp. 42–53. Available at: https://doi.org/10.1016/S1474-4422(11)70263-0.
Tabrizi, S.J. et al. (2013) ‘Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data’, The Lancet Neurology, 12(7), pp. 637–649. Available at: https://doi.org/10.1016/S1474-4422(13)70088-7.
Thal, D.R. (2004) ‘Neurodegeneration in Normal Brain Aging and Disease’, Science of Aging Knowledge Environment, 2004(23), pp. pe26–pe26. Available at: https://doi.org/10.1126/sageke.2004.23.pe26.
UK National Guidelines for HIV Testing 2008 (no date). Available at: https://www.bhiva.org/HIV-testing-guidelines.
Walker, Z. et al. (2015) ‘Lewy body dementias’, The Lancet, 386(10004), pp. 1683–1697. Available at: https://doi.org/10.1016/S0140-6736(15)00462-6.
Warren, J.D., Rohrer, J.D. and Rossor, M.N. (2013) ‘Frontotemporal dementia’, BMJ, 347(aug12 3), pp. f4827–f4827. Available at: https://doi.org/10.1136/bmj.f4827.
Weil, R.S. et al. (2017) ‘Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies’, F1000Research, 6. Available at: https://doi.org/10.12688/f1000research.11725.1.
Wendorf, K.A. et al. (2017) ‘Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated’, Clinical Infectious Diseases, 65(2), pp. 226–232. Available at: https://doi.org/10.1093/cid/cix302.
Wild, E.J. and Tabrizi, S.J. (2017) ‘Therapies targeting DNA and RNA in Huntington’s disease’, The Lancet Neurology, 16(10), pp. 837–847. Available at: https://doi.org/10.1016/S1474-4422(17)30280-6.
Woollacott, I.O.C. and Rohrer, J.D. (2016) ‘The clinical spectrum of sporadic and familial forms of frontotemporal dementia’, Journal of Neurochemistry, 138, pp. 6–31. Available at: https://doi.org/10.1111/jnc.13654.
Zhou, L., Miranda-Saksena, M. and Saksena, N.K. (2013) ‘Viruses and neurodegeneration’, Virology Journal, 10(1). Available at: https://doi.org/10.1186/1743-422X-10-172.
